We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRAY
651
DELISTED
ViewRay, Inc.
VRAY
$1.7M 0.02%
468,000
+268,000
+134% +$899K
POWL icon
652
Powell Industries
POWL
$6.79B
$1.69M 0.02%
240,843
LFMD icon
653
LifeMD
LFMD
$176M
$1.68M 0.02%
852,544
+260,058
+44% +$620K
RGLD icon
654
Royal Gold
RGLD
$16.6B
$1.68M 0.02%
17,900
MN
655
DELISTED
MANNING & NAPIER, INC.
MN
$1.68M 0.02%
136,600
GILD icon
656
Gilead Sciences
GILD
$165B
$1.67M 0.02%
27,000
RJET
657
Republic Airways Holdings
RJET
$845M
$1.66M 0.02%
66,982
-60,764
-48% -$2.08M
KMX icon
658
CarMax
KMX
$8.39B
$1.65M 0.02%
24,975
+17,075
+216% +$1.56M
LILAK icon
659
Liberty Latin America Class C
LILAK
$1.69B
$1.6M 0.02%
287,153
-206,580
-42% -$1.33M
WKC icon
660
World Kinect Corp
WKC
$2.06B
$1.6M 0.02%
68,084
-39,592
-37% -$982K
DLX icon
661
Deluxe
DLX
$1.25B
$1.58M 0.02%
95,067
-537,839
-85% -$11.3M
FOCS
662
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$1.58M 0.02%
50,000
MDXG icon
663
MiMedx Group
MDXG
$630M
$1.56M 0.02%
+545,000
New +$1.94M
AMRC icon
664
Ameresco
AMRC
$980M
$1.56M 0.02%
23,500
-71,000
-75% -$4.36M
EZPW icon
665
Ezcorp Inc
EZPW
$1.79B
$1.55M 0.02%
201,000
GXO icon
666
GXO Logistics
GXO
$5.93B
$1.54M 0.02%
+44,000
New +$1.94M
LARK icon
667
Landmark Bancorp
LARK
$195M
$1.54M 0.02%
73,007
-9,023
-11% -$189K
SUPN icon
668
Supernus Pharmaceuticals
SUPN
$2.7B
$1.51M 0.02%
44,735
-156
-0.3% -$5.08K
GGG icon
669
Graco
GGG
$13.2B
$1.51M 0.02%
25,224
ATIP
670
DELISTED
ATI Physical Therapy, Inc.
ATIP
$1.47M 0.02%
29,436
BIOX icon
671
Bioceres Crop Solutions
BIOX
$20.6M
$1.47M 0.02%
113,000
+45,000
+66% +$552K
HCC icon
672
Warrior Met Coal
HCC
$4.17B
$1.47M 0.02%
51,644
+20,061
+64% +$617K
NTCT icon
673
NETSCOUT
NTCT
$2.83B
$1.46M 0.02%
46,609
+10,553
+29% +$345K
VALU icon
674
Value Line
VALU
$333M
$1.44M 0.02%
32,832
-15,874
-33% -$1.15M
MXCT icon
675
MaxCyte
MXCT
$108M
$1.44M 0.02%
221,325
+108,325
+96% +$604K

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.